Literature DB >> 11604560

Platelets, leukocytes, and coagulation.

B A Bouchard1, P B Tracy.   

Abstract

Considerable data now support the hypothesis that platelets actively regulate the propagation of coagulation by (1) expressing specific, high-affinity receptors for coagulation proteases, zymogens, and cofactors; (2) protecting the bound coagulation enzymes from inactivation/inhibition; (3) restricting coagulant activity to the site of vascular injury; and (4) amplifying the initiating stimulus to lead to explosive thrombin generation. Thrombin generation is sustained at the site of vascular injury by the recruitment of circulating monocytes and neutrophils to the growing thrombus via the interaction of PSGL-1, which is constitutively expressed by leukocytes, with P-selectin, which is expressed by activated platelets. Unique among cells, monocytes can provide the appropriate membrane surface for the assembly and function of all the coagulation complexes required for tissue factor-initiated thrombin production. More studies are required to further delineate the roles of neutrophils and lymphocytes in the procoagulant response. This review will discuss the recent investigations and controversies regarding the various mechanisms by which platelets and leukocytes function in, and regulate, thrombin generation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11604560     DOI: 10.1097/00062752-200109000-00001

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  21 in total

Review 1.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

2.  Leukocyte Count and Intracerebral Hemorrhage Expansion.

Authors:  Andrea Morotti; Chia-Ling Phuah; Christopher D Anderson; Michael J Jessel; Kristin Schwab; Alison M Ayres; Alessandro Pezzini; Alessandro Padovani; M Edip Gurol; Anand Viswanathan; Steven M Greenberg; Joshua N Goldstein; Jonathan Rosand
Journal:  Stroke       Date:  2016-04-21       Impact factor: 7.914

Review 3.  In Vitro models for thrombogenicity testing of blood-recirculating medical devices.

Authors:  Deepika N Sarode; Shuvo Roy
Journal:  Expert Rev Med Devices       Date:  2019-06-10       Impact factor: 3.166

4.  New insights into the spatiotemporal localization of prothrombinase in vivo.

Authors:  Lacramioara Ivanciu; Sriram Krishnaswamy; Rodney M Camire
Journal:  Blood       Date:  2014-05-28       Impact factor: 22.113

Review 5.  Spatiotemporal regulation of coagulation and platelet activation during the hemostatic response in vivo.

Authors:  L Ivanciu; T J Stalker
Journal:  J Thromb Haemost       Date:  2015-10-23       Impact factor: 5.824

6.  Loss of estrogen receptor beta decreases mitochondrial energetic potential and increases thrombogenicity of platelets in aged female mice.

Authors:  Muthuvel Jayachandran; Claudia C Preston; Larry W Hunter; Arshad Jahangir; Whyte G Owen; Kenneth S Korach; Virginia M Miller
Journal:  Age (Dordr)       Date:  2009-11-12

7.  Ability of the Khorana score to predict recurrent thromboembolism in cancer patients with ischemic stroke.

Authors:  Santosh B Murthy; Mary Cushman; Dylan Bobrow; Hooman Kamel; Alexander E Merkler; Mitchell S V Elkind; Lisa M DeAngelis; Babak B Navi
Journal:  J Clin Neurosci       Date:  2018-08-23       Impact factor: 1.961

8.  Platelet aggregation in humans and nonhuman primates: relevance to xenotransplantation.

Authors:  Hayato Iwase; Burcin Ekser; Hao Zhou; Eefje M Dons; David K C Cooper; Mohamed B Ezzelarab
Journal:  Xenotransplantation       Date:  2012 Jul-Aug       Impact factor: 3.907

Review 9.  Role of cellular elements in thrombus formation and dissolution.

Authors:  N Wohner
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2008-07

10.  The influence of platelet activating factor on the effects of platelet agonists and antiplatelet agents in vitro.

Authors:  Friederike K Keating; David J Schneider
Journal:  J Thromb Thrombolysis       Date:  2008-06-25       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.